Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Invested Capital (2021 - 2025)

Senti Biosciences has reported Invested Capital over the past 5 years, most recently at $5.6 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 78.21% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $5.6 million, down 78.21%, while the annual FY2025 figure was $5.6 million, 78.21% down from the prior year.
  • Invested Capital for Q4 2025 was $5.6 million at Senti Biosciences, down from $8.1 million in the prior quarter.
  • Over five years, Invested Capital peaked at $154.3 million in Q2 2022 and troughed at -$121.8 million in Q1 2022.
  • A 5-year average of $24.8 million and a median of $31.8 million in 2024 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: skyrocketed 270.2% in 2022 and later plummeted 80.69% in 2024.
  • Year by year, Invested Capital stood at -$111.5 million in 2021, then surged by 214.18% to $127.3 million in 2022, then crashed by 47.42% to $66.9 million in 2023, then tumbled by 61.67% to $25.6 million in 2024, then tumbled by 78.21% to $5.6 million in 2025.
  • Business Quant data shows Invested Capital for SNTI at $5.6 million in Q4 2025, $8.1 million in Q3 2025, and $24.7 million in Q2 2025.